Literature DB >> 7729877

Endobronchial inflammation following Pseudomonas aeruginosa infection in resistant and susceptible strains of mice.

C Morissette1, E Skamene, F Gervais.   

Abstract

The early endobronchial inflammation induced by Pseudomonas aeruginosa infection varies in resistant and susceptible strains of mice. Mice of the DBA/2 strain are severely afflicted by the infection, with a high bacterial burden accumulating rapidly following inoculation and a high mortality rate occurring. Mice of the BALB/c strain are resistant to infection and clear the bacteria within 3 to 7 days. Infection of (BALB/c x DBA/2)F1 hybrid mice showed that the resistance to lung P. aeruginosa infection is inherited as a dominant trait. Mice of the A/J and C57BL/6 strains were found to have an intermediate phenotype to Pseudomonas aeruginosa infection when compared with BALB/c and DBA/2 strains. The decrease in the bacterial load seen early after infection coincided with a steady and strong recruitment of inflammatory cells to the bronchoalveolar spaces of mice of the resistant BALB/c strain. On the other hand, the recruitment of inflammatory cells to the lungs of mice of the susceptible DBA/2 strain was deficient, resulting in the failure to control bacterial multiplication. Chemotactic factors, proinflammatory cytokines, and the number and function of recruited inflammatory cells may play major roles in the determination of the genetic resistance to lung infection with P. aeruginosa in a normal immunocompetent host.

Entities:  

Mesh:

Year:  1995        PMID: 7729877      PMCID: PMC173215          DOI: 10.1128/iai.63.5.1718-1724.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Influence of genetic factors on natural resistance of mice to Pseudomonas aeruginosa.

Authors:  J E Pennington; R M Williams
Journal:  J Infect Dis       Date:  1979-04       Impact factor: 5.226

2.  Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration.

Authors:  R S Baltimore; C D Christie; G J Smith
Journal:  Am Rev Respir Dis       Date:  1989-12

3.  Further studies on the genetic control of murine corneal response to Pseudomonas aeruginosa.

Authors:  R S Berk; L D Hazlett
Journal:  Rev Infect Dis       Date:  1983 Nov-Dec

4.  Mechanisms of complement-mediated clearance of bacteria from the murine lung.

Authors:  P J Heidbrink; G B Toews; G N Gross; A K Pierce
Journal:  Am Rev Respir Dis       Date:  1982-05

5.  Genetic control of resistance to Listeria monocytogenes: regulation of leukocyte inflammatory responses by the Hc locus.

Authors:  F Gervais; M Stevenson; E Skamene
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

6.  Specific pulmonary defences against Pseudomonas aeruginosa after local immunization with temperature-sensitive mutants.

Authors:  D O Sordelli; M C Cerquetti; J A Bellanti; A Morris Hooke
Journal:  J Gen Microbiol       Date:  1987-10

7.  The pulmonary response of C5 sufficient and deficient mice to Pseudomonas aeruginosa.

Authors:  G L Larsen; B C Mitchell; T B Harper; P M Henson
Journal:  Am Rev Respir Dis       Date:  1982-08

8.  Effect of chemotactins released by Staphylococcus aureus and Pseudomonas aeruginosa on the murine respiratory tract.

Authors:  D O Sordelli; M C Cerquetti; A Morris Hooke; J A Bellanti
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

9.  Inflammatory responses to Pseudomonas aeruginosa and Staphylococcus aureus in the murine lung.

Authors:  D O Sordelli; B J Zeligs; M C Cerquetti; A Morris Hooke; J A Bellanti
Journal:  Eur J Respir Dis       Date:  1985-01

10.  Impaired lung defenses against Staphylococcus aureus in mice with hereditary deficiency of the fifth component of complement.

Authors:  M C Cerquetti; D O Sordelli; R A Ortegon; J A Bellanti
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

View more
  34 in total

1.  TLRs and NODs mRNA expression pattern in healthy mouse eye.

Authors:  S Rodríguez-Martínez; M E Cancino-Díaz; L Jiménez-Zamudio; E García-Latorre; J C Cancino-Díaz
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

2.  Pseudomonas aeruginosa exoenzyme S stimulates murine lymphocyte proliferation in vitro.

Authors:  N G Barclay; J C Spurrell; T F Bruno; D G Storey; D E Woods; C H Mody
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 3.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

4.  Quantitative and qualitative differences in bronchoalveolar inflammatory cells in Pseudomonas aeruginosa-resistant and -susceptible mice.

Authors:  K Sapru; P K Stotland; M M Stevenson
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

5.  Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model.

Authors:  Alessandra Bragonzi; Dieter Worlitzsch; Gerald B Pier; Petra Timpert; Martina Ulrich; Morten Hentzer; Jens Bo Andersen; Michael Givskov; Massimo Conese; Gerd Doring
Journal:  J Infect Dis       Date:  2005-06-24       Impact factor: 5.226

6.  Defect in early lung defence against Pseudomonas aeruginosa in DBA/2 mice is associated with acute inflammatory lung injury and reduced bactericidal activity in naive macrophages.

Authors:  Kari R Wilson; Jennifer M Napper; James Denvir; Vincent E Sollars; Hongwei D Yu
Journal:  Microbiology       Date:  2007-04       Impact factor: 2.777

7.  Model of differential susceptibility to mucosal Burkholderia pseudomallei infection.

Authors:  Boping Liu; Ghee Chong Koo; Eu Hian Yap; Kim Lee Chua; Yunn-Hwen Gan
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

8.  Interleukin-4 enhances pulmonary clearance of Pseudomonas aeruginosa.

Authors:  S Jain-Vora; A M LeVine; Z Chroneos; G F Ross; W M Hull; J A Whitsett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Antipseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung.

Authors:  Rishi Pabary; Charanjit Singh; Sandra Morales; Andrew Bush; Khalid Alshafi; Diana Bilton; Eric W F W Alton; Anthony Smithyman; Jane C Davies
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

10.  Modification of in vivo and in vitro T- and B-cell-mediated immune responses by the Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone.

Authors:  Adam J Ritchie; Andrew O W Yam; Kara M Tanabe; Scott A Rice; Margaret A Cooley
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.